This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Plaque Psoriasis
and you are
between 18 and 80
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

This study will provide data on additional therapeutic benefits in administering Adalimumab in patients with plaque psoriasis that showed an unsatisfactory response after at least 3 months of treatment with etanercept.

Provided treatments

  • Drug: Adalimumab every other week
  • Drug: Adalimumab Every Week
Tris trial is registered with FDA with number: NCT00927069. The sponsor of the trial is Innovaderm Research Inc. and it is looking for 85 volunteers for the current phase.
Official trial title:
Open Label Study to Evaluate the Efficacy and Safety of Adalimumab in Patients With Plaque Psoriasis Who Showed an Unsatisfactory Response to Etanercept